Sloand, E <br/><br/>
The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.  [electronic resource] 

 -  Bone marrow transplantation  Nov 2003 
 - 897-901 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Graft vs Leukemia Effect--drug effects<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality<br/>Leukemia, Myeloid, Chronic-Phase--mortality<br/>Male<br/>Middle Aged<br/>Peripheral Blood Stem Cell Transplantation--methods<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Transplantation, Isogeneic<br/>Treatment Outcome<br/>Vidarabine--administration & dosage